Jessica D. Sun

2.5k total citations
47 papers, 1.7k citations indexed

About

Jessica D. Sun is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jessica D. Sun has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 19 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Jessica D. Sun's work include Cancer, Hypoxia, and Metabolism (22 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Jessica D. Sun is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Jessica D. Sun collaborates with scholars based in United States, Spain and Netherlands. Jessica D. Sun's co-authors include Renata Pasqualini, Charles P. Hart, Wadih Arap, Dharmendra Ahluwalia, Roberto Rangel, Mark D. Matteucci, Qian Liu, Ricardo J. Giordano, Mikhail G. Kolonin and Marina Cardó‐Vila and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Jessica D. Sun

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jessica D. Sun United States	20	906	645	471	293	251	47	1.7k
Martin Hagedorn France	28	1.5k 1.7×	468 0.7×	442 0.9×	257 0.9×	221 0.9×	42	2.2k
Anat Erdreich‐Epstein United States	27	957 1.1×	380 0.6×	311 0.7×	82 0.3×	269 1.1×	60	1.9k
Jennifer R. Allport United States	20	835 0.9×	282 0.4×	327 0.7×	384 1.3×	559 2.2×	25	2.2k
Karim Y. Helmy United States	18	848 0.9×	464 0.7×	407 0.9×	113 0.4×	859 3.4×	20	2.2k
Martine L.M. Lamfers Netherlands	33	1.5k 1.7×	465 0.7×	1.0k 2.2×	147 0.5×	368 1.5×	98	2.7k
Martina Rudelius Germany	31	1.1k 1.2×	366 0.6×	902 1.9×	306 1.0×	590 2.4×	89	3.0k
Marina Cardó‐Vila United States	25	1.0k 1.1×	243 0.4×	376 0.8×	431 1.5×	345 1.4×	31	1.7k
Martin Lenter Germany	26	1.6k 1.8×	564 0.9×	879 1.9×	222 0.8×	599 2.4×	44	3.1k
Peter Nollau Germany	25	1.2k 1.3×	218 0.3×	825 1.8×	539 1.8×	396 1.6×	48	2.5k

Countries citing papers authored by Jessica D. Sun

Since Specialization

Citations

This map shows the geographic impact of Jessica D. Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica D. Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica D. Sun more than expected).

Fields of papers citing papers by Jessica D. Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica D. Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica D. Sun. The network helps show where Jessica D. Sun may publish in the future.

Co-authorship network of co-authors of Jessica D. Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica D. Sun. A scholar is included among the top collaborators of Jessica D. Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica D. Sun. Jessica D. Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Craven, Gregory B., Hang Chu, Jessica D. Sun, et al.. (2024). Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation. Nature. 637(8044). 205–214. 9 indexed citations

Sun, Jessica D., et al.. (2020). Validation of the traditional script Chinese version of the brief negative symptom scale. Asian Journal of Psychiatry. 55. 102522–102522. 11 indexed citations

Du, Xiaohui, John Eksterowicz, Haiying Zhou, et al.. (2019). Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633). Journal of Medicinal Chemistry. 62(14). 6751–6764. 5 indexed citations

Kumar, Sushil, Jessica D. Sun, Libo Zhang, et al.. (2018). Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models. Translational Oncology. 11(4). 911–919. 14 indexed citations

Durán, Rafael, Sahar Mirpour, Shanmugasundaram Ganapathy‐Kanniappan, et al.. (2016). Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. Clinical Cancer Research. 23(2). 536–548. 25 indexed citations

Sun, Jessica D., Qian Liu, Dharmendra Ahluwalia, et al.. (2016). Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models. Cancer Biology & Therapy. 17(4). 371–380. 21 indexed citations

Peeters, Sarah G.J.A., Catharina M.L. Zegers, Rianne Biemans, et al.. (2015). TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging. Clinical Cancer Research. 21(13). 2984–2992. 85 indexed citations

Meng, Fanying, Jessica D. Sun, Qian Liu, et al.. (2015). Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition. BMC Cancer. 15(1). 422–422. 21 indexed citations

Brenner, Andrew, Jessica D. Sun, John Floyd, et al.. (2014). Phase 1/2 study of investigational hypoxia-targeted drug, TH-302, and bevacizumab (bev) in recurrent glioblastoma (GBM) following bev failure.. Journal of Clinical Oncology. 32(15_suppl). 2029–2029. 1 indexed citations

10.

Marchiò, Serena, Marco Soster, Andrea Muratore, et al.. (2012). A complex of α ₆ integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6. EMBO Molecular Medicine. 4(11). 1156–1175. 39 indexed citations

11.

Liu, Qian, Jessica D. Sun, Jingli Wang, et al.. (2012). TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules. Cancer Chemotherapy and Pharmacology. 69(6). 1487–1498. 86 indexed citations

12.

Sun, Jessica D., Qian Liu, Jingli Wang, et al.. (2011). Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer. Clinical Cancer Research. 18(3). 758–770. 142 indexed citations

13.

Duan, Jianxin, Xiaohong Cai, Fanying Meng, et al.. (2011). 14-Aminocamptothecins: Their Synthesis, Preclinical Activity, and Potential Use for Cancer Treatment. Journal of Medicinal Chemistry. 54(6). 1715–1723. 15 indexed citations

14.

Hu, Jinsong, Damian Handisides, Els Van Valckenborgh, et al.. (2010). Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug. Blood. 116(9). 1524–1527. 113 indexed citations

15.

Staquicini, Fernanda I., Anita Tandle, Steven K. Libutti, et al.. (2008). A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans. Cancer Research. 68(20). 8419–8428. 59 indexed citations

16.

Cardó‐Vila, Marina, Amado J. Zurita, Ricardo J. Giordano, et al.. (2008). A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11. PLoS ONE. 3(10). e3452–e3452. 25 indexed citations

17.

Jaalouk, Diana E., Michael G. Ozawa, Jessica D. Sun, et al.. (2007). The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor–Binding Site within Neuropilin-1. Cancer Research. 67(20). 9623–9629. 11 indexed citations

18.

Rangel, Roberto, Yan Sun, Liliana Guzman‐Rojas, et al.. (2007). Impaired angiogenesis in aminopeptidase N-null mice. Proceedings of the National Academy of Sciences. 104(11). 4588–4593. 106 indexed citations

19.

Ji, Yuan, Guosheng Yin, Mikhail G. Kolonin, et al.. (2007). Bayesian Mixture Models for Complex High Dimensional Count Data in Phage Display Experiments. Journal of the Royal Statistical Society Series C (Applied Statistics). 56(2). 139–152. 3 indexed citations

20.

Kolonin, Mikhail G., Laura Bover, Jessica D. Sun, et al.. (2006). Ligand-Directed Surface Profiling of Human Cancer Cells with Combinatorial Peptide Libraries. Cancer Research. 66(1). 34–40. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact